Janus Kinase (JAK) Inhibitor Drugs Market Advances with Expanding Use of Targeted Therapies for Autoimmune and Inflammatory Disorders
According to the latest report published by Data Bridge Market Research, the Janus Kinases (JAKs) Inhibitor Drugs Market Data Bridge Market Research analyses that the Janus kinases (JAKs) inhibitor drugs market, which is USD 2.45 billion in 2022, is expected to reach USD 5.11 billion by 2030, at a CAGR of 9.6% during the forecast period 2023 to 2030 Global Janus Kinases (JAKs)...
0 Comentários 0 Compartilhamentos 2 Visualizações